Return of results in the genomic medicine projects of the eMERGE network

Iftikhar Jan Kullo, Ra'ad Haddad, Cynthia A. Prows, Ingrid Holm, Saskia C. Sanderson, Nanibaa' A. Garrison, Richard R Sharp, Maureen E. Smith, Helena Kuivaniemi, Erwin P. Bottinger, John J. Connolly, Brendan J. Keating, Catherine A. McCarty, Marc S. Williams, Gail P. Jarvik

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The electronic Medical Records and Genomics (eMERGE) (Phase I) network was established in 2007 to further genomic discovery using biorepositories linked to the electronic health record (EHR). In Phase II, which began in 2011, genomic discovery efforts continue and in addition the network is investigating best practices for implementing genomic medicine, in particular, the return of genomic results in the EHR for use by physicians at point-of-care. To develop strategies for addressing the challenges of implementing genomic medicine in the clinical setting, the eMERGE network is conducting studies that return clinically-relevant genomic results to research participants and their health care providers. These genomic medicine pilot studies include returning individual genetic variants associated with disease susceptibility or drug response, as well as genetic risk scores for common "complex" disorders. Additionally, as part of a network-wide pharmacogenomics-related project, targeted resequencing of 84 pharmacogenes is being performed and select genotypes of pharmacogenetic relevance are being placed in the EHR to guide individualized drug therapy. Individual sites within the eMERGE network are exploring mechanisms to address incidental findings generated by resequencing of the 84 pharmacogenes. In this paper, we describe studies being conducted within the eMERGE network to develop best practices for integrating genomic findings into the EHR, and the challenges associated with such work.

Original languageEnglish (US)
Article numberArticle 50
JournalFrontiers in Genetics
Volume5
Issue numberMAR
StatePublished - 2014

Fingerprint

Electronic Health Records
Genomics
Medicine
Pharmacogenetics
Practice Guidelines
Point-of-Care Systems
Incidental Findings
Clinical Medicine
Disease Susceptibility
Health Personnel
Genotype
Physicians
Drug Therapy
Research
Pharmaceutical Preparations

Keywords

  • Electronic health records
  • Genetic counseling
  • Genomics
  • Implementation
  • Incidental findings
  • Next generation sequencing
  • Pharmacogenetics

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Genetics(clinical)

Cite this

Kullo, I. J., Haddad, R., Prows, C. A., Holm, I., Sanderson, S. C., Garrison, N. A., ... Jarvik, G. P. (2014). Return of results in the genomic medicine projects of the eMERGE network. Frontiers in Genetics, 5(MAR), [Article 50].

Return of results in the genomic medicine projects of the eMERGE network. / Kullo, Iftikhar Jan; Haddad, Ra'ad; Prows, Cynthia A.; Holm, Ingrid; Sanderson, Saskia C.; Garrison, Nanibaa' A.; Sharp, Richard R; Smith, Maureen E.; Kuivaniemi, Helena; Bottinger, Erwin P.; Connolly, John J.; Keating, Brendan J.; McCarty, Catherine A.; Williams, Marc S.; Jarvik, Gail P.

In: Frontiers in Genetics, Vol. 5, No. MAR, Article 50, 2014.

Research output: Contribution to journalArticle

Kullo, IJ, Haddad, R, Prows, CA, Holm, I, Sanderson, SC, Garrison, NA, Sharp, RR, Smith, ME, Kuivaniemi, H, Bottinger, EP, Connolly, JJ, Keating, BJ, McCarty, CA, Williams, MS & Jarvik, GP 2014, 'Return of results in the genomic medicine projects of the eMERGE network', Frontiers in Genetics, vol. 5, no. MAR, Article 50.
Kullo IJ, Haddad R, Prows CA, Holm I, Sanderson SC, Garrison NA et al. Return of results in the genomic medicine projects of the eMERGE network. Frontiers in Genetics. 2014;5(MAR). Article 50.
Kullo, Iftikhar Jan ; Haddad, Ra'ad ; Prows, Cynthia A. ; Holm, Ingrid ; Sanderson, Saskia C. ; Garrison, Nanibaa' A. ; Sharp, Richard R ; Smith, Maureen E. ; Kuivaniemi, Helena ; Bottinger, Erwin P. ; Connolly, John J. ; Keating, Brendan J. ; McCarty, Catherine A. ; Williams, Marc S. ; Jarvik, Gail P. / Return of results in the genomic medicine projects of the eMERGE network. In: Frontiers in Genetics. 2014 ; Vol. 5, No. MAR.
@article{c7e2efd63f3c4cdf858cb4ce7fde315f,
title = "Return of results in the genomic medicine projects of the eMERGE network",
abstract = "The electronic Medical Records and Genomics (eMERGE) (Phase I) network was established in 2007 to further genomic discovery using biorepositories linked to the electronic health record (EHR). In Phase II, which began in 2011, genomic discovery efforts continue and in addition the network is investigating best practices for implementing genomic medicine, in particular, the return of genomic results in the EHR for use by physicians at point-of-care. To develop strategies for addressing the challenges of implementing genomic medicine in the clinical setting, the eMERGE network is conducting studies that return clinically-relevant genomic results to research participants and their health care providers. These genomic medicine pilot studies include returning individual genetic variants associated with disease susceptibility or drug response, as well as genetic risk scores for common {"}complex{"} disorders. Additionally, as part of a network-wide pharmacogenomics-related project, targeted resequencing of 84 pharmacogenes is being performed and select genotypes of pharmacogenetic relevance are being placed in the EHR to guide individualized drug therapy. Individual sites within the eMERGE network are exploring mechanisms to address incidental findings generated by resequencing of the 84 pharmacogenes. In this paper, we describe studies being conducted within the eMERGE network to develop best practices for integrating genomic findings into the EHR, and the challenges associated with such work.",
keywords = "Electronic health records, Genetic counseling, Genomics, Implementation, Incidental findings, Next generation sequencing, Pharmacogenetics",
author = "Kullo, {Iftikhar Jan} and Ra'ad Haddad and Prows, {Cynthia A.} and Ingrid Holm and Sanderson, {Saskia C.} and Garrison, {Nanibaa' A.} and Sharp, {Richard R} and Smith, {Maureen E.} and Helena Kuivaniemi and Bottinger, {Erwin P.} and Connolly, {John J.} and Keating, {Brendan J.} and McCarty, {Catherine A.} and Williams, {Marc S.} and Jarvik, {Gail P.}",
year = "2014",
language = "English (US)",
volume = "5",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "MAR",

}

TY - JOUR

T1 - Return of results in the genomic medicine projects of the eMERGE network

AU - Kullo, Iftikhar Jan

AU - Haddad, Ra'ad

AU - Prows, Cynthia A.

AU - Holm, Ingrid

AU - Sanderson, Saskia C.

AU - Garrison, Nanibaa' A.

AU - Sharp, Richard R

AU - Smith, Maureen E.

AU - Kuivaniemi, Helena

AU - Bottinger, Erwin P.

AU - Connolly, John J.

AU - Keating, Brendan J.

AU - McCarty, Catherine A.

AU - Williams, Marc S.

AU - Jarvik, Gail P.

PY - 2014

Y1 - 2014

N2 - The electronic Medical Records and Genomics (eMERGE) (Phase I) network was established in 2007 to further genomic discovery using biorepositories linked to the electronic health record (EHR). In Phase II, which began in 2011, genomic discovery efforts continue and in addition the network is investigating best practices for implementing genomic medicine, in particular, the return of genomic results in the EHR for use by physicians at point-of-care. To develop strategies for addressing the challenges of implementing genomic medicine in the clinical setting, the eMERGE network is conducting studies that return clinically-relevant genomic results to research participants and their health care providers. These genomic medicine pilot studies include returning individual genetic variants associated with disease susceptibility or drug response, as well as genetic risk scores for common "complex" disorders. Additionally, as part of a network-wide pharmacogenomics-related project, targeted resequencing of 84 pharmacogenes is being performed and select genotypes of pharmacogenetic relevance are being placed in the EHR to guide individualized drug therapy. Individual sites within the eMERGE network are exploring mechanisms to address incidental findings generated by resequencing of the 84 pharmacogenes. In this paper, we describe studies being conducted within the eMERGE network to develop best practices for integrating genomic findings into the EHR, and the challenges associated with such work.

AB - The electronic Medical Records and Genomics (eMERGE) (Phase I) network was established in 2007 to further genomic discovery using biorepositories linked to the electronic health record (EHR). In Phase II, which began in 2011, genomic discovery efforts continue and in addition the network is investigating best practices for implementing genomic medicine, in particular, the return of genomic results in the EHR for use by physicians at point-of-care. To develop strategies for addressing the challenges of implementing genomic medicine in the clinical setting, the eMERGE network is conducting studies that return clinically-relevant genomic results to research participants and their health care providers. These genomic medicine pilot studies include returning individual genetic variants associated with disease susceptibility or drug response, as well as genetic risk scores for common "complex" disorders. Additionally, as part of a network-wide pharmacogenomics-related project, targeted resequencing of 84 pharmacogenes is being performed and select genotypes of pharmacogenetic relevance are being placed in the EHR to guide individualized drug therapy. Individual sites within the eMERGE network are exploring mechanisms to address incidental findings generated by resequencing of the 84 pharmacogenes. In this paper, we describe studies being conducted within the eMERGE network to develop best practices for integrating genomic findings into the EHR, and the challenges associated with such work.

KW - Electronic health records

KW - Genetic counseling

KW - Genomics

KW - Implementation

KW - Incidental findings

KW - Next generation sequencing

KW - Pharmacogenetics

UR - http://www.scopus.com/inward/record.url?scp=84897743970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897743970&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84897743970

VL - 5

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - MAR

M1 - Article 50

ER -